Chronic CoughChronic coughNCT07190664
A Prospective, Randomized, Double-blind Study on the Effects of Different Anesthesia Strategies on Postoperative Cough in Patients Undergoing Video-assisted Thoracoscopic Surgery.
A study testing Patients were randomly grouped in people with Chronic Cough and Video-assisted Thoracoscopic Surgery (VATS), run by Fujian Medical University Union Hospital.
Trial summary
This study aims to systematically evaluate the effects of different anesthesia methods on postoperative chronic cough in lung cancer patients undergoing video-assisted thoracoscopic lung resection (VATS), and to clarify the effectiveness and safety of each anesthesia airway management strategy in reducing the… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Chronic Cough, Video-assisted Thoracoscopic Surgery (VATS)
- What is being tested?
- Patients were randomly grouped
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 228 participants
- Where
- No sites listed yet
- Study dates
- 1 Oct 2025to 30 Dec 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- planned wedge resection, segmentectomy or lobectomy;
- more than 18 years old;
- American Society of Anesthesiologists (ASA) grade ≤Ⅲ;
- body mass index (BMI) ≤24 kg/m2;
- Normal pulmonary function, predicted forced expiratory volume in 1 second (FEV1%) >50%, resting blood gas analysis showed arterial partial pressure of oxygen (PaO2) ≥75 mmHg and arterial partial pressure of carbon dioxide (PaCO2) <45 MMHG;
- Normal cardiac function with ejection fraction (EF) > 50% of predicted value;
- Informed consent and signed informed consent form.
Who cannot join
- (1) patients who refuse surgery and/or anesthesia; (2) preoperative pulmonary infection; (3) previous history of ipsilateral surgery or other medical history that may cause extensive pleural adhesions; (4) phrenic nerve palsy on the non-operative side; (5) patients with high risk of preoperative reflux (fasting <6 hours) or gastroesophageal reflux disease; (6) patients with heart, kidney, liver and other organ dysfunction and surgical contraindications; (7) with severe cognitive, psychological and communication disorders.
About this study
Official title: A Prospective, Randomized, Double-blind Study of Different Anesthesia Strategies for Postoperative Cough in Patients Undergoing Video-assisted Thoracoscopic Surgery
This study aims to systematically evaluate the effects of different anesthesia methods on postoperative chronic cough in lung cancer patients undergoing video-assisted thoracoscopic lung resection (VATS), and to clarify the effectiveness and safety of each anesthesia airway management strategy in reducing the incidence of postoperative chronic cough, shortening the duration of cough, alleviating the severity of symptoms, and improving the postoperative quality of life of patients.
Read the detailed description
This study is a single-center, prospective, randomized, double-blind controlled study, aiming to explore the effects of different airway management strategies during surgery on the postoperative chronic cough in patients undergoing video-assisted thoracoscopic (VATS) lung resection. The study focuses on evaluating the incidence, duration, severity of postoperative chronic cough and its impact on patients' quality of life. It is expected to provide a basis for the prevention and intervention of postoperative chronic cough through prospective clinical data.
This study adopted a prospective, randomized, double-blind controlled design. The subjects were randomly divided into the single-lumen endotracheal tube group (Group A), the double-lumen endotracheal tube group (Group B), and the laryngeal mask airway group (Group C) in a 1:1:1 ratio to evaluate the effects of different airway management methods on postoperative chronic cough. The specific process is as follows: 1. Random sequence generation: The random grouping sequence was generated by independent non-clinical researchers using computer programs (such as SPSS, Excel or professional randomization tools), ensuring an equal distribution ratio, a repeatable process, and randomness. 2. Group information management: Each subject was assigned a unique random number, and this number and the group results were pre-loaded into opaque sealed envelopes and stored in order of the number. All envelopes were kept by a dedicated coordinator, who did not participate in the subsequent anesthesia or follow-up process to ensure the blinding of the grouping. 3. Group execution process: After the patient completed enrollment and signed the informed consent form, the research coordinator would open the envelope containing the subject's number before the operation, obtain the corresponding group information, and notify the anesthesiologist to execute the anesthesia strategy according to the predetermined grouping. The subjects and post-visit personnel remained blind to the grouping.
To ensure the ethical and safety aspects of the research, the following handling mechanisms have been established: 1. For patients who are not suitable for a certain anesthesia method before the operation: The anesthesiologist will conduct an assessment before the operation. If it is determined that they are not suitable for a certain anesthesia method, they will not proceed with the randomization process and will be registered as "Screening Failure", and will not be included in the intention-to-treat (ITT) analysis. 2. For those who need to change the intubation method due to uncontrollable factors during the operation (such as poor laryngeal mask ventilation and switching to intubation): Their original group will be retained for the ITT analysis. At the same time, a per-protocol (PP) analysis will be conducted in the data statistics for sensitivity analysis, and the reasons for the change will be detailed. 3. For those who did not complete the surgery during the operation or were lost to follow-up after the operation: If the subjects withdrew or were lost to follow-up, they will still be recorded as dropout and included in the dropout analysis. The endpoints to be included will be determined based on the degree of follow-up completion.
To reduce observation bias and analysis bias, this study was designed as a double-blind study. 1. Blind subjects: The postoperative visit personnel (responsible for assessing cough and quality of life scores) and data statisticians remained blind; the subjects were not clear about the intubation method during the operation (general anesthesia during the operation); the anesthesiologists were not blind (as they needed to perform the intubation operation). 2. Measures to ensure blinding: The anesthesiologists were not allowed to participate in any postoperative follow-up or data processing; the group information was hidden in the medical records and research forms, and was only identified by numbers.
The study observation period consists of two stages: the perioperative period and the postoperative chronic period. The follow-up time points during the perioperative period are on the 1st, 2nd, 3rd, 7th, 14th, and 1st month after the surgery; the follow-up time points during the postoperative chronic period are set at the 3rd, 6th, and 12th month after the surgery. The main focus of the study is to observe the incidence of postoperative chronic cough, the duration of coughing, the severity score, and the impact of coughing on quality of life. In addition, secondary indicators such as re-visits due to coughing and drug intervention can also be recorded to further evaluate the impact of the intervention measures on the long-term prognosis of the patients.
- Being tested
- Patients were randomly grouped
- Keywords
- Video-assisted thoracoscopic surgery, chronic cough
- Medical subject headings
- Chronic Cough
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patients were randomly groupedOther
All patients included in the study, were randomized
| Study group | Role | What they receive |
|---|---|---|
| Single-lumen endotracheal intubation group | Active comparator | During the process of general anesthesia, a single-lumen endotracheal tube combined with a bronchial blocker was used to perform pulmonary isolation surgery, thereby meeting the requirements of video-assisted thoracoscopic partial lung resection.sample size:76 Receives: Other: Patients were randomly grouped |
| Double-lumen endotracheal tube group | Active comparator | During the general anesthesia process, a double-lumen endotracheal tube was used for lung isolation surgery, thus meeting the requirements of video-assisted thoracoscopic partial lung resection.sample size:76 Receives: Other: Patients were randomly grouped |
| Laryngeal mask group | Experimental | During the general anesthesia procedure, a laryngeal mask was used, and the patient maintained spontaneous breathing for the thoracoscopic partial lung resection surgery.sample size:76 Receives: Other: Patients were randomly grouped |
What is being measured
The primary outcome is the main question the study is designed to answer.
The incidence of postoperative chronic cough, cough duration and cough severity score were recorded
The perioperative follow-up time points were 1 day, 2 days, 3 days, 7 days, 14 days and 1 month after operation. The follow-up time points of postoperative chronic phase were set at 3 months, 6 months and 12 months after operation.
Measured: The perioperative follow-up time points were 1 day, 2 days, 3 days, 7 days, 14 days and 1 month after operation. The follow-up time points of postoperative chronic phase were set at 3 months, 6 months and 12 months after operation.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Sep 2025
- Study start1 Oct 2025 (estimated)
- Primary completion1 Dec 2025 (estimated)
- Study completion30 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic CoughStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 228 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fujian Medical University Union Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07190664
- Sponsor's protocol ID
- 2025KY282
- Acronym
- Chronic cough
- Status last verified
- Jun 2025
- First submitted
- 17 Sep 2025
- Last updated
- 24 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prospective, Randomized, Double-blind Study of Different Anesthesia Strategies for Postoperative Cough in Patients Undergoing Video-assisted Thoracoscopic Surgery
- ClinicalTrials.gov ID
- NCT07190664
- Acronym / sponsor ID
- Chronic cough / 2025KY282
- Keywords
- Video-assisted thoracoscopic surgery, chronic cough
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 228 participants (estimated)
- Lead sponsor
- Fujian Medical University Union HospitalUniversity, hospital or other
- Study start
- 1 Oct 2025 (estimated)
- Primary completion
- 1 Dec 2025 (estimated)
- Study completion
- 30 Dec 2025 (estimated)
- First posted
- 24 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to systematically evaluate the effects of different anesthesia methods on postoperative chronic cough in lung cancer patients undergoing video-assisted thoracoscopic lung resection (VATS), and to clarify the effectiveness and safety of each anesthesia airway management strategy in reducing the incidence of postoperative chronic cough, shortening the duration of cough, alleviating the severity of symptoms, and improving the postoperative quality of life of patients.
Detailed description
This study is a single-center, prospective, randomized, double-blind controlled study, aiming to explore the effects of different airway management strategies during surgery on the postoperative chronic cough in patients undergoing video-assisted thoracoscopic (VATS) lung resection. The study focuses on evaluating the incidence, duration, severity of postoperative chronic cough and its impact on patients' quality of life. It is expected to provide a basis for the prevention and intervention of postoperative chronic cough through prospective clinical data.
This study adopted a prospective, randomized, double-blind controlled design. The subjects were randomly divided into the single-lumen endotracheal tube group (Group A), the double-lumen endotracheal tube group (Group B), and the laryngeal mask airway group (Group C) in a 1:1:1 ratio to evaluate the effects of different airway management methods on postoperative chronic cough. The specific process is as follows: 1. Random sequence generation: The random grouping sequence was generated by independent non-clinical researchers using computer programs (such as SPSS, Excel or professional randomization tools), ensuring an equal distribution ratio, a repeatable process, and randomness. 2. Group information management: Each subject was assigned a unique random number, and this number and the group results were pre-loaded into opaque sealed envelopes and stored in order of the number. All envelopes were kept by a dedicated coordinator, who did not participate in the subsequent anesthesia or follow-up process to ensure the blinding of the grouping. 3. Group execution process: After the patient completed enrollment and signed the informed consent form, the research coordinator would open the envelope containing the subject's number before the operation, obtain the corresponding group information, and notify the anesthesiologist to execute the anesthesia strategy according to the predetermined grouping. The subjects and post-visit personnel remained blind to the grouping.
To ensure the ethical and safety aspects of the research, the following handling mechanisms have been established: 1. For patients who are not suitable for a certain anesthesia method before the operation: The anesthesiologist will conduct an assessment before the operation. If it is determined that they are not suitable for a certain anesthesia method, they will not proceed with the randomization process and will be registered as "Screening Failure", and will not be included in the intention-to-treat (ITT) analysis. 2. For those who need to change the intubation method due to uncontrollable factors during the operation (such as poor laryngeal mask ventilation and switching to intubation): Their original group will be retained for the ITT analysis. At the same time, a per-protocol (PP) analysis will be conducted in the data statistics for sensitivity analysis, and the reasons for the change will be detailed. 3. For those who did not complete the surgery during the operation or were lost to follow-up after the operation: If the subjects withdrew or were lost to follow-up, they will still be recorded as dropout and included in the dropout analysis. The endpoints to be included will be determined based on the degree of follow-up completion.
To reduce observation bias and analysis bias, this study was designed as a double-blind study. 1. Blind subjects: The postoperative visit personnel (responsible for assessing cough and quality of life scores) and data statisticians remained blind; the subjects were not clear about the intubation method during the operation (general anesthesia during the operation); the anesthesiologists were not blind (as they needed to perform the intubation operation). 2. Measures to ensure blinding: The anesthesiologists were not allowed to participate in any postoperative follow-up or data processing; the group information was hidden in the medical records and research forms, and was only identified by numbers.
The study observation period consists of two stages: the perioperative period and the postoperative chronic period. The follow-up time points during the perioperative period are on the 1st, 2nd, 3rd, 7th, 14th, and 1st month after the surgery; the follow-up time points during the postoperative chronic period are set at the 3rd, 6th, and 12th month after the surgery. The main focus of the study is to observe the incidence of postoperative chronic cough, the duration of coughing, the severity score, and the impact of coughing on quality of life. In addition, secondary indicators such as re-visits due to coughing and drug intervention can also be recorded to further evaluate the impact of the intervention measures on the long-term prognosis of the patients.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Single-lumen endotracheal intubation group | Active comparator | Other: Patients were randomly groupedDuring the process of general anesthesia, a single-lumen endotracheal tube combined with a bronchial blocker was used to perform pulmonary isolation surgery, thereby meeting the requirements of video-assisted thoracoscopic partial lung resection.sample size:76 |
| Double-lumen endotracheal tube group | Active comparator | Other: Patients were randomly groupedDuring the general anesthesia process, a double-lumen endotracheal tube was used for lung isolation surgery, thus meeting the requirements of video-assisted thoracoscopic partial lung resection.sample size:76 |
| Laryngeal mask group | Experimental | Other: Patients were randomly groupedDuring the general anesthesia procedure, a laryngeal mask was used, and the patient maintained spontaneous breathing for the thoracoscopic partial lung resection surgery.sample size:76 |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- planned wedge resection, segmentectomy or lobectomy;
- more than 18 years old;
- American Society of Anesthesiologists (ASA) grade ≤Ⅲ;
- body mass index (BMI) ≤24 kg/m2;
- Normal pulmonary function, predicted forced expiratory volume in 1 second (FEV1%) >50%, resting blood gas analysis showed arterial partial pressure of oxygen (PaO2) ≥75 mmHg and arterial partial pressure of carbon dioxide (PaCO2) <45 MMHG;
Key exclusion criteria (1 listed)
- (1) patients who refuse surgery and/or anesthesia; (2) preoperative pulmonary infection; (3) previous history of ipsilateral surgery or other medical history that may cause extensive pleural adhesions; (4) phrenic nerve palsy on the non-operative side; (5) patients with high risk of preoperative reflux (fasting <6 hours) or gastroesophageal reflux disease; (6) patients with heart, kidney, liver and other organ dysfunction and surgical contraindications; (7) with severe cognitive, psychological and communication disorders.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patients were randomly groupedAll patients included in the study, were randomized | Other | Double-lumen endotracheal tube group, Laryngeal mask group, Single-lumen endotracheal intubation group |
Primary outcome
The incidence of postoperative chronic cough, cough duration and cough severity score were recorded
Time frame: The perioperative follow-up time points were 1 day, 2 days, 3 days, 7 days, 14 days and 1 month after operation. The follow-up time points of postoperative chronic phase were set at 3 months, 6 months and 12 months after operation.
The perioperative follow-up time points were 1 day, 2 days, 3 days, 7 days, 14 days and 1 month after operation. The follow-up time points of postoperative chronic phase were set at 3 months, 6 months and 12 months after operation.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Sep 2025.
Related trials for Chronic Cough
Not yet recruitingPhase 4
A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough
Cough, Refractory Chronic Cough
RecruitingPhase 2
A Study to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic Cough
Refractory Chronic Cough and Unexplained Chronic Cough
RecruitingPhase 3
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)
Refractory Chronic Cough
RecruitingPhase 3
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets
Idiopathic Pulmonary Fibrosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Patients were randomly grouped in people with Chronic Cough and Video-assisted Thoracoscopic Surgery (VATS), run by Fujian Medical University Union Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 24 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The incidence of postoperative chronic cough, cough duration and cough severity score were recorded (time frame: The perioperative follow-up time points were 1 day, 2 days, 3 days, 7 days, 14 days and 1 month after operation. The follow-up time points of postoperative chronic phase were set at 3 months, 6 months and 12 months after operation.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2025.